Sunshine Biopharma Inc.
SBFMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $2.57K in total; no superinvestor holds it.
Other share classesSBFM
Holders of 5% or more of SBFMW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sunshine Biopharma Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Sunshine Biopharma Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Sunshine Biopharma Inc., newest first.
No Schedule 13D or 13G filings on Sunshine Biopharma Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sunshine Biopharma Inc. shares.
No Form 144 notices for Sunshine Biopharma Inc. are on file.